Maduck Sean, SR, reported a transaction classified as exercise at CORCEPT THERAPEUTICS INC involving 3664.000000 shares for an estimated $0.00. Reported holdings after the transaction were 91986.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
Form 4 relationship flags and nearby filing context
See Remarks
Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to th…
This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction.
Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.
Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager.
Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
Fully exercisable.
0 other filings
0 recent txs